|
Inhalation toxicity of brevetoxin 3 in rats exposed for twenty-two days.(Brevetoxins: Mini-Monograph)
From:
Environmental Health Perspectives
| Date:
May 1, 2005| Author:
Benson, Janet M.; Hahn, Fletcher F.; March, Thomas H.; McDonald, Jacob D.; Gomez, Andrea P.; Sopori, Mohan J.; Bourdelais, Andrea J.; Naar, Jerome; Zaias, Julia; Bossart, Gregory D.; Baden, Daniel G.
| COPYRIGHT 2005 National Institute of Environmental Health Sciences. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
Brevetoxins are potent neurotoxins produced by the marine dinoflagellate Karenia brevis. Exposure to brevetoxins may occur during a K. brevis red tide when the compounds become aerosolized by wind and surf. This study assessed possible adverse health effects associated with inhalation exposure to brevetoxin 3, one of the major brevetoxins produced by K. brevis and present in aerosols collected along beaches affected by red tide. Male F344 rats were exposed to brevetoxin 3 at 0, 37,...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Telithromycin offers a path to tailored treatment in respiratory infections.(Infectious Diseases)
Internal Medicine News
; ORLANDO, FLA. -- Telithromycin is an excellent first-line choice for empiric outpatient treatment of mild-to-moderate respiratory tract infections, Carman A. Ciervo, D.O., declared at a satellite symposium held in conjunction with Wonca 2004, the conference of the World Organization of Family
|
|
Respiratory tract reinfections by the new human metapneumovirus in an immunocompromised child. (Dispatches).
Emerging Infectious Diseases
; The human metapneumovirus (HMPV), a new member of the paramyxoviridae family, has been recently associated with respiratory tract infections in young children. We report the case of a young, immunocompromised child who had severe lower respiratory tract infections during two consecutive winter
|
|
Vitamin E.(NUTRACEUTICALS RESEARCH)(Brief Article)
Nutraceuticals World
; Nutraceutical: Vitamin E Indication: Respiratory tract infections Source: JAMA, August 18, 2004;292(7):828-836. Research: In this randomized, double-blind, placebo-controlled study, researchers assessed the impact of 200 IU of vitamin E per day on the incidence of respiratory tract infections
|
|
Vaccine effective against hMPV.(Clinical Capsules)(human metapneumovirus)(Brief Article)
Pediatric News
; Lower respiratory tract infections associated with human metapneumovirus were reduced by 45%, and clinical pneumonia was reduced by 55% among non-HIV-infected children who had received at least three doses of 9-valent conjugate pneumococcal vaccine, Dr. Shabir A. Madhi reported in a poster
|
|
Phytomedicines for respiratory tract diseases. 1st edition.(Book Review)
Phytomedicine: International Journal of Phytotherapy & Phytopharmacology
; Phytomedicines for respiratory tract diseases. 1st edition S. Chrubasic, B. Roufogalis. Australian Pharmaceutical Publishing Company, Balmain, NSW, Australia, 2002, 80 p., price $27.50, ISBN 0-9580664-0-X (SC) Herbal medicinal products play an important role in the treatment of respiratory tract
|